Guttman-Yassky E, Blauvelt A, Eichenfield L, Paller A, Armstrong A, Drew J, Gopalan R, Simpson E. Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 3];4(6):s94. Available from: https://jofskin.org/33014/index.php/skin/article/view/1064